Inovio Pharmaceuticals, Inc. (INO) — Dilution Risk Analysis

Current Snapshot

Inovio Pharmaceuticals, Inc. (INO) has a DilutionWatch score of 87/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
103,397,518 Source
Public Float
81,929,335 Source
Float as % of Outstanding
79.2%

Dilution Risk Score

Score: 87/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: SC 13G/A 2, SC 13G 2, 8-K 1, EFFECT 1, XBRL 1, 4 3.

FormFiledAccession
SC 13G/A 2026-08-12 0000919574-26-004959
SC 13G 2026-08-07 0001346824-26-000216
SC 13G/A 2026-08-06 0000315066-26-002045
8-K 2026-07-31 0001193125-26-326785
SC 13G 2026-07-31 0002100119-26-001406
EFFECT 2026-07-10 9999999995-26-002261
xbrl 2026-06-30 xbrl-5315-xbrl_warrant
4 2026-05-21 0001771498-26-000005
4 2026-05-21 0001259780-26-000006
4 2026-05-21 0001936799-26-000006

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $17,500,000 Source
Cash runway 3 months Source
Three-year share count growth 278.76% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 87/10) Source
Cash Runway
3 months Source
ATM Offering Capacity Remaining
$17,500,000 Source
Share Count Growth (3-Year)
278.76% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.